These data indicate that although B7-H3.CAR-T cells effectively controlled NSCLC tumor growth in orthotopic and metastatic models, they cannot eradicate tumor cells located in the brain, which may be due to the BBB hampering CAR-T cell trafficking. The gene discussed is CD276; the disease is neoplasm.